E-LIB Suche - Ergebnisse für: Hochhaus, J

1

Structural, chemical, and magnetic investigation of a graph..:

Weinert, P ; Hochhaus, J ; Kesper, L...
Nanotechnology. 35 (2024) 16 - p. 165702 , 2024

Link: https://doi.org/10.1088/..

2

The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 ..:

Hammersen, J. ; Birndt, S. ; Döhner, K....
Leukemia. 37 (2023) 9 - p. 1879-1886 , 2023

Link: https://doi.org/10.1038/..

3

CO169 Pan-Stakeholder Core Outcome Set (COS) Definition for..:

Lang, K. ; Bereczky, T. ; Geissler, J....
Value in Health. 26 (2023) 12 - p. S44 , 2023

Link: https://doi.org/10.1016/..

4

P707: DOSE MODIFICATION DYNAMICS OF PONATINIB IN PATIENTS W..:

Apperley, J. ; Kantarjian, H. ; Deininger, M....
HemaSphere. 6 (2022) - p. 602-603 , 2022

Link: https://doi.org/10.1097/..

5

S155: EFFICACY AND SAFETY RESULTS FROM ASCEMBL, A PHASE 3 S..:

Rea, D. ; Hochhaus, A. ; Mauro, M. J....
HemaSphere. 6 (2022) - p. 56-57 , 2022

Link: https://doi.org/10.1097/..

6

P704: ASCIMINIB PROVIDES DURABLE MOLECULAR RESPONSES IN PAT..:

Hughes, T. ; Cortes, J. E. ; Réa, D....
HemaSphere. 6 (2022) - p. 599-600 , 2022

Link: https://doi.org/10.1097/..

7

P719: EFFICACY AND SAFETY OF BOSUTINIB IN LATER-LINE PATIEN..:

Gambacorti-Passerini, C. ; Brümmendorf, T. H. ; Ernst, T....
HemaSphere. 6 (2022) - p. 614-615 , 2022

Link: https://doi.org/10.1097/..

8

PB1902: ASC4OPT TRIAL IN PROGRESS: A PHASE 3B OPEN-LABEL OP..:

Breccia, M. ; Turkina, A. ; Boquimpani, C....
HemaSphere. 6 (2022) - p. 1781-1782 , 2022

Link: https://doi.org/10.1097/..

9

Molekulare Onkologie:

Hochhaus, A. ; Krause, M. ; Schmidberger, H.
Der Onkologe. 28 (2022) 2 - p. 92-94 , 2022

Link: https://doi.org/10.1007/..

10

P1055: CLINICAL AND GENETIC RESULTS OF THE PHASE IB/II TRIA..:

Stegelmann, F. ; Jahn, E. ; Koschmieder, S....
HemaSphere. 6 (2022) - p. 945-946 , 2022

Link: https://doi.org/10.1097/..

11

PB1904: TRIAL IN PROGRESS: A PHASE III STUDY OF ASCIMINIB V..:

Hughes, T. ; Cortes, J. ; Takahashi, N....
HemaSphere. 6 (2022) - p. 1783-1784 , 2022

Link: https://doi.org/10.1097/..

12

MSR19 A Matching-Adjusted Indirect Comparison of Asciminib ..:

Atallah, EL ; Maheshwari, V ; Mauro, MJ...
Value in Health. 25 (2022) 7 - p. S521 , 2022

Link: https://doi.org/10.1016/..

13

The impact of specific cytokine directed treatment on sever..:

Reuken, P. A. ; Rüthrich, M. M. ; Hochhaus, A....
Leukemia. 35 (2021) 12 - p. 3613-3615 , 2021

Link: https://doi.org/10.1038/..

14

Interdisziplinäres COVID-Board bei SARS-CoV-2-getriggerter ..:

La Rosée, P. ; Bremer, H.-C. ; La Rosée, F....
Medizinische Klinik - Intensivmedizin und Notfallmedizin. 116 (2020) 2 - p. 138-145 , 2020

Link: https://doi.org/10.1007/..

15

Holding CoVID in check through JAK? The MPN-approved compou..:

Heidel, F. ; Hochhaus, A.
Leukemia. 34 (2020) 7 - p. 1723-1725 , 2020

Link: https://doi.org/10.1038/..